FDA product code QJZ: Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure
QJZ is the FDA product code for extracorporeal system for long-term respiratory / cardiopulmonary failure. It is a Class II device, regulated under 21 CFR 870.4100 and reviewed by the Cardiovascular panel. FDA has cleared 4 510(k) submissions under QJZ, 3 in the last five years, from 2 different applicants. The average 510(k) review took 185 days (median 186); 142 days on average over the last three years. FDA has posted 2 recalls for QJZ devices, 2 initiated in the last five years.
Definition
Extracorporeal circuit and accessories for long-term respiratory/cardiopulmonary failure.
Classification
| Field | Value |
|---|---|
| Device name | Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure |
| Device class | Class II |
| Regulation | 21 CFR 870.4100 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Life-sustaining or supporting | Yes |
510(k) clearances per year for QJZ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2020 | 1 | 269 |
| 2024 | 2 | 186 |
| 2026 | 1 | 99 |
Compare with all 510(k) review times · Search every QJZ clearance
Top QJZ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Medtronic, Inc. | 2 | 2026-07-31 |
| Fresenius Medical Care Renal Therapies Group, LLC | 2 | 2024-04-15 |
Most recent QJZ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K261335 | Medtronic, Inc. | VitalFlow Set with Balance Biosurface | 2026-07-31 | 99 |
| K240880 | Medtronic, Inc. | VitalFlow Set with Balance Biosurface | 2024-09-12 | 164 |
| K232926 | Fresenius Medical Care Renal Therapies Group, LLC | Novalung ultimate kit (US) | 2024-04-15 | 208 |
| K191407 | Fresenius Medical Care Renal Therapies Group, LLC | Novalung System | 2020-02-21 | 269 |
Recalls for QJZ devices
2 product recalls in 2 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2024-04-08.
| Year | Recalls |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
Frequently asked questions
What is FDA product code QJZ?
QJZ is the FDA product code for extracorporeal system for long-term respiratory / cardiopulmonary failure. It is a Class II device, regulated under 21 CFR 870.4100 and reviewed by the Cardiovascular panel.
What device class is QJZ?
Class II, regulation 21 CFR 870.4100. Typical premarket route: 510(k).
How long does a 510(k) take for product code QJZ?
Across 4 cleared submissions the average was 185 days from receipt to decision (median 186).
Which companies have the most QJZ clearances?
Medtronic, Inc. (2); Fresenius Medical Care Renal Therapies Group, LLC (2).
Have QJZ devices been recalled?
Yes: 2 product recalls across 2 recall events; the most recent began 2024-04-08.
Next steps
- Run an FDA pathway report with predicate devices for product code QJZ
- Run a recall and safety report across every QJZ manufacturer
- Watch product code QJZ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times